Literature DB >> 8273275

Adaptation of the Sensititre broth microdilution technique to antimicrobial susceptibility testing of Mycoplasma hyopneumoniae.

A C Tanner1, B Z Erickson, R F Ross.   

Abstract

A broth microdilution technique is described for determining the antimicrobial susceptibility of Mycoplasma hyopneumoniae, using commercially prepared Sensititre plates. Twenty-five field isolates and two reference strains (J & 232), were tested against seven antimicrobials. Field isolates were tested in duplicate and reference strains, four times to estimate reproducibility. Ninety-seven percent of the duplicate MIC results for the field isolates were in agreement, or within one log2 dilution. Similar results were obtained with the reference strains. The isolates were susceptible to lincomycin-spectinomycin, tylosin and oxytetracycline or resistant to amoxycillin, apramycin and erythromycin. Susceptibility to furaltadone varied. This method retains the accuracy and reproducibility of broth MIC determinations, while avoiding the lengthy preparation of antimicrobial dilutions normally associated with more traditional methods.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8273275     DOI: 10.1016/0378-1135(93)90096-p

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  4 in total

1.  In vitro susceptibilities of Mycoplasma hyopneumoniae field isolates.

Authors:  J Vicca; T Stakenborg; D Maes; P Butaye; J Peeters; A de Kruif; F Haesebrouck
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

2.  Antimicrobial susceptibility and genetic profile of Mycoplasma hyopneumoniae isolates from Brazil.

Authors:  Natália Fialho Gonzaga; Luiz Fernando Lino de Souza; Marcus Rebouças Santos; Viviane Sisdelli Assao; Andrew Rycroft; Alannah Saskia Deeney; Juliana Lopes Rangel Fietto; Gustavo Costa Bressan; Maria Aparecida Scatamburlo Moreira; Abelardo Silva-Júnior
Journal:  Braz J Microbiol       Date:  2019-12-03       Impact factor: 2.476

3.  Analysis of the mutant selection window and killing of Mycoplasma hyopneumoniae for doxycycline, tylosin, danofloxacin, tiamulin, and valnemulin.

Authors:  Zilong Huang; Chunxiao Mao; Yanzhe Wei; Xiaoyan Gu; Qinren Cai; Xiangguang Shen; Huanzhong Ding
Journal:  PLoS One       Date:  2020-06-16       Impact factor: 3.240

4.  Pharmacokinetic/Pharmacodynamic Integration of Doxycycline Against Mycoplasma hyopneumoniae in an In Vitro Model.

Authors:  Huilin Zhang; Chunxiao Mao; Jinju Li; Zilong Huang; Xiaoyan Gu; Xiangguang Shen; Huanzhong Ding
Journal:  Front Pharmacol       Date:  2019-09-20       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.